Font Size: a A A
Keyword [Diffuse large B cell lymphoma(DLBCL)]
Result: 41 - 48 | Page: 3 of 3
41. Clinical Characteristics And Prognostic Value Analysis Of DLBCL Patients With TP53 Gene Variation Detected By Next Generation Sequencing And FISH
42. Application Of Circulating Tumor DNA In Diffuse Large B-cell Lymphoma
43. Expression And Role Of Mir-525-5p And MyD88/NF-κB Regulatory Pathway In Diffuse Large B Cell Lymphoma
44. Study On The Mechanism And Drug Sensitivity Of Hsa-miR-28-5p/YWHAZ Axis In Diffuse Large B Cell Lymphoma
45. The Exploratory Research In Vitro Of DLBCL Treatment Through PI3K Inhibitor YY-20394
46. Expression And Significance Of APOC1、APOE Protein In Diffuse Large B-cell Lymphoma
47. Relationship Between Immune Checkpoint Expression And Pathological Features And Prognosis In The Immune Microenvironment Of Diffuse Large B-cell Lymphoma
48. Impact Of Diagnosis-to-Treatment-Interval And Treatment-Delay-Time On Outcomes Of Patients With Diffuse Large B-cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to